Christina Melief, PhD
Senior Scientific Advisor for Customer Ready Products, NMDP/Be the Match
Dr. Christina Leonhard Melief is a visionary in the field of cell therapy and stem cells, and a compassionate leader for medical science professionals and their patients. In her previous role as co-founder of the Center To Cure, she served as interim Chairman of the Board, President, and CEO, guiding the organization's efforts to advance translational medicine and bridge the gap between patients, doctors, and researchers. With a deep understanding of the complexities of rare diseases, Dr. Melief is dedicated to improving the lives of those affected by these conditions.
Dr. Melief holds a Ph.D. in Genetics from Stonybrook University and a BS in Molecular, Cellular, and Developmental Biology from the University of Washington. Her diverse background in basic science research, including DNA damage repair in Drosophila, pluripotent cell contribution in zebrafish, cell fate and transdetermination in Drosophila, and early embryonic development of mice, has equipped her with a unique and comprehensive perspective on the field.
Her doctoral research in glycobiology was groundbreaking, as it allowed her to contribute to the knowledge of glycoproteins associated with several rare diseases. This exposure to the field of glycobiology sparked Dr. Melief's passion to advance rare disease research and her desire to contribute to translational medicine. With her extensive background and expertise, she is a true advocate for patients and their families and is committed to making a difference in the lives of those affected by rare diseases.
With her leadership, dedication, and passion, Dr. Christina Leonhard Melief is a driving force in the field of rare disease research, working tirelessly to bring hope and improved outcomes to those in need. Whether through her role at the Center To Cure or through her tireless efforts to improve the lives of those affected by rare diseases, she is truly making a difference in the world.